Obesity Forum® FAQs: A Podcast Series
This activity is supported by an educational grant from Lilly.
Click Here to Manage Email Alerts
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Lilly.
This activity is endorsed by the 
Activity Description
Obesity is an increasingly prevalent, chronic condition associated with substantial risks of morbidity and mortality. It is also a risk factor for some of the leading causes of preventable death, including cardiovascular disease, stroke, type 2 diabetes mellitus, sleep apnea, gallbladder disease, osteoarthritis, and certain types of cancer. The 12th Annual Obesity Forum was a 2-part series that provided healthcare professionals with guidance on the appropriate use of therapies as well as strategies for delivering individualized care to patients of any age with overweight or obesity via interprofessional strategies. In this podcast series, experts in the management of patients with overweight and obesity answer questions submitted during the Obesity Forum activities.
Target Audience
The intended audience for this activity is endocrinologists, family medicine physicians, internists, pharmacists, dietitians, nurse practitioners, and physician associates involved in the management of patients with overweight and obesity.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate patient preferences, interprofessional strategies, and shared decision-making for improved outcomes in people with obesity.
- Discuss the latest clinical evidence for the pharmacological management of people with overweight and obesity including long-term data regarding weight regain after cessation of medication.
- Employ nonpharmacological interventions such as lifestyle modifications including diet, exercise, and behavioral interventions to aid in effective long-term weight management.
Activity Chair
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine
Northwestern Medicine
Chicago, IL
Faculty
Deborah Bade Horn, DO, MPH, MFOMA
Medical Director
University of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP)
Associate Professor
University of Texas McGovern Medical School, Department of Surgery
Program Director
UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance
Bellaire, TX
Leigh Perreault, MD, FACE, FACP
Associate Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
Affiliate, Center for Global Health
University of Colorado Anschutz Medical Campus
Associate Professor of Epidemiology and Biostatistics
Colorado School of Public Health
Aurora, CO
Donna H. Ryan, MD, FACP, FTOS
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, BS, PA-C
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.
This program is acceptable for 1.25 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-24-080-H01-P, effective 10/31/2024. This is a knowledge-based activity, and there is no fee to attend.
Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until October 30, 2025. PAs should only claim credit commensurate with the extent of their participation.
This This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
The Commission on Dietetic Registration (CDR) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Participants of this enduring activity may submit CME credits earned to the American Board of Obesity Medicine (ABOM) for certification requirements.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
This enduring material is approved for 1 year from the date of original release, October 31, 2024, to October 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, listen to the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate, Statement of Continuing Pharmacy Education Credit, or AAPA Category 1 CME certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Deborah Bade Horn, DO, MPH, MFOMA
Consultant: Amgen, Lilly, Novo Nordisk
Speaker Contracted by Ineligible Company: Lilly, Novo Nordisk
Independent Research Contractor: KVK Tech, Lilly, Novo Nordisk, WeightWatchers
Robert F. Kushner, MD, MS, FACP, FTOS, DABOM
Advisor: Altimmune, Boehringer Ingelheim, Lilly, Novo Nordisk, Regeneron, Structure, WeightWatchers
Consultant: Currax, Epitomee
Leigh Perreault, MD, FACE, FACP
Advisor: Boehringer Ingelheim, Lilly, Novo Nordisk
Speaker Contracted by Ineligible Company: Boehringer Ingelheim, Lilly, Novo Nordisk
Donna H. Ryan, MD, FACP, FTOS
Advisor: Altimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Biohaven, Calibrate, Carmot/Roche, CinRx, Currax, Epitomee, Fractyl, Gila, Lilly, Nestle, Novo Nordisk, Regeneron, Scientific Intake, Structure Therapeutics, Wondr Health, Zealand
Speaker Contracted by Ineligible Company: Lilly, Novo Nordisk
Independent Research Contractor: CinRx, (Rhythm), Lilly
Stock Options: Calibrate, Epitomee, Roman, Scientific Intake
SELECT Steering Committee: Novo Nordisk
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Disclaimer
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the complete activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com